ArticleJNCI cancer spectrum2022

Real-World Evidence Prediction of a Phase IV Oncology Trial: Comparative Degarelix vs Leuprolide Safety.

David Merola et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.